These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29550015)

  • 1. CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy international registry: Design and rationale of the DERIVATE study.
    Guaricci AI; Masci PG; Lorenzoni V; Schwitter J; Pontone G
    Int J Cardiol; 2018 Jun; 261():223-227. PubMed ID: 29550015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry.
    Pontone G; Guaricci AI; Fusini L; Baggiano A; Guglielmo M; Muscogiuri G; Volpe A; Abete R; Aquaro G; Barison A; Bogaert J; Camastra G; Carigi S; Carrabba N; Casavecchia G; Censi S; Cicala G; De Cecco CN; De Lazzari M; Di Giovine G; Di Roma M; Dobrovie M; Focardi M; Gaibazzi N; Gismondi A; Gravina M; Lanzillo C; Lombardi M; Lorenzoni V; Lozano-Torres J; Martini C; Marzo F; Masi A; Memeo R; Moro C; Nese A; Palumbo A; Pavon AG; Pedrotti P; Marra MP; Pica S; Pradella S; Presicci C; Rabbat MG; Raineri C; Rodriguez-Palomares JF; Sbarbati S; Schoepf UJ; Squeri A; Sverzellati N; Symons R; Tat E; Timpani M; Todiere G; Valentini A; Varga-Szemes A; Masci PG; Schwitter J
    JACC Cardiovasc Imaging; 2023 Nov; 16(11):1387-1400. PubMed ID: 37227329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international Registry.
    Guaricci AI; Masci PG; Muscogiuri G; Guglielmo M; Baggiano A; Fusini L; Lorenzoni V; Martini C; Andreini D; Pavon AG; Aquaro GD; Barison A; Todiere G; Rabbat MG; Tat E; Raineri C; Valentini A; Varga-Szemes A; Schoepf UJ; De Cecco CN; Bogaert J; Dobrovie M; Symons R; Focardi M; Gismondi A; Lozano-Torres J; Rodriguez-Palomares JF; Lanzillo C; Di Roma M; Moro C; Di Giovine G; Margonato D; De Lazzari M; Perazzolo Marra M; Nese A; Casavecchia G; Gravina M; Marzo F; Carigi S; Pica S; Lombardi M; Censi S; Squeri A; Palumbo A; Gaibazzi N; Camastra G; Sbarbati S; Pedrotti P; Masi A; Carrabba N; Pradella S; Timpani M; Cicala G; Presicci C; Puglisi S; Sverzellati N; Santobuono VE; Pepi M; Schwitter J; Pontone G
    Europace; 2021 Jul; 23(7):1072-1083. PubMed ID: 33792661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AI Cardiac MRI Scar Analysis Aids Prediction of Major Arrhythmic Events in the Multicenter DERIVATE Registry.
    Ghanbari F; Joyce T; Lorenzoni V; Guaricci AI; Pavon AG; Fusini L; Andreini D; Rabbat MG; Aquaro GD; Abete R; Bogaert J; Camastra G; Carigi S; Carrabba N; Casavecchia G; Censi S; Cicala G; De Cecco CN; De Lazzari M; Di Giovine G; Di Roma M; Focardi M; Gaibazzi N; Gismondi A; Gravina M; Lanzillo C; Lombardi M; Lozano-Torres J; Masi A; Moro C; Muscogiuri G; Nese A; Pradella S; Sbarbati S; Schoepf UJ; Valentini A; Crelier G; Masci PG; Pontone G; Kozerke S; Schwitter J
    Radiology; 2023 May; 307(3):e222239. PubMed ID: 36943075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy.
    Demirel F; Adiyaman A; Timmer JR; Dambrink JH; Kok M; Boeve WJ; Elvan A
    Int J Cardiol; 2014 Dec; 177(2):392-9. PubMed ID: 25440471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance.
    Champ-Rigot L; Gay P; Seita F; Benouda L; Morello R; Pellissier A; Alexandre J; Saloux E; Milliez P
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):48. PubMed ID: 32580786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy.
    Al'Aref SJ; Altibi AM; Malkawi A; Mansour M; Baskaran L; Masri A; Rahmouni H; Abete R; Andreini D; Aquaro G; Barison A; Bogaert J; Camastra G; Carigi S; Carrabba N; Casavecchia G; Censi S; Cicala G; Conte E; De Cecco CN; De Lazzari M; Di Giovine G; Di Roma M; Dobrovie M; Focardi M; Gaibazzi N; Gismondi A; Gravina M; Guglielmo M; Lanzillo C; Lombardi M; Lorenzoni V; Lozano-Torres J; Margonato D; Martini C; Marzo F; Masci P; Masi A; Memeo R; Moro C; Mushtaq S; Nese A; Palumbo A; Pavon AG; Pedrotti P; Pepi M; Perazzolo Marra M; Pica S; Pradella S; Presicci C; Rabbat MG; Raineri C; Rodriguez-Palomares JF; Sbarbati S; Schoepf UJ; Squeri A; Sverzellati N; Symons R; Tat E; Timpani M; Todiere G; Valentini A; Varga-Szemes A; Volpe A; Fusini L; Guaricci AI; Schwitter J; Pontone G
    Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):472-482. PubMed ID: 35792682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.
    Keil L; Chevalier C; Kirchhof P; Blankenberg S; Lund G; Müllerleile K; Magnussen C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.
    Zhang Y; Guallar E; Weiss RG; Stillabower M; Gerstenblith G; Tomaselli GF; Wu KC
    Heart Rhythm; 2016 Aug; 13(8):1661-6. PubMed ID: 27108939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac magnetic resonance imaging and primary prevention implantable cardioverter defibrillator therapy: current recommendations and future directions.
    Guaricci AI; De Santis D; Rabbat MG; Pontone G
    J Cardiovasc Med (Hagerstown); 2018 May; 19(5):223-228. PubMed ID: 29561311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Impact of Cardiac Magnetic Resonance Imaging Versus Echocardiography-Guided Patient Selection for Primary Prevention Implantable Cardioverter Defibrillator Therapy.
    Rijnierse MT; van der Lingen AL; Weiland MT; de Haan S; Nijveldt R; Beek AM; van Rossum AC; Allaart CP
    Am J Cardiol; 2015 Aug; 116(3):406-12. PubMed ID: 26050137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms.
    Lindemann F; Oebel S; Paetsch I; Arya A; Dagres N; Richter S; Dinov B; Hilbert S; Loebe S; Stegmann C; Doering M; Bollmann A; Hindricks G; Jahnke C
    J Cardiovasc Magn Reson; 2020 May; 22(1):32. PubMed ID: 32389126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study.
    Dubner S; Valero E; Pesce R; Zuelgaray JG; Mateos JC; Filho SG; Reyes W; Garillo R
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):420-8. PubMed ID: 16255752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure).
    Flett A; Cebula A; Nicholas Z; Adam R; Ewings S; Prasad S; Cleland JG; Eminton Z; Curzen N
    Am Heart J; 2023 Dec; 266():149-158. PubMed ID: 37777041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.